Literature DB >> 7377837

Raised somatomedin associated with normal growth hormone. A cause of Beckwith-Wiedemann syndrome?

G S Spencer, F Schabel, H Frisch.   

Abstract

A child with Beckwith-Wiedemann syndrome is described. Growth hormone levels were normal, but circulating somatomedin activity was increased. The role of somatomedins in this condition, and the possibility of a feedback mechanism controlling somatomedin production are discussed.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7377837      PMCID： PMC1626669          DOI： 10.1136/adc.55.2.151

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  8 in total

1.  ANTIBODY-SUPPRESSIBLE AND NONSUPPRESSIBLE INSULIN-LIKE ACTIVITIES IN HUMAN SERUM AND THEIR PHYSIOLOGIC SIGNIFICANCE. AN INSULIN ASSAY WITH ADIPOSE TISSUE OF INCREASED PRECISION AND SPECIFICITY.

Authors:  E R FROESCH; H BUERGI; E B RAMSEIER; P BALLY; A LABHART
Journal:  J Clin Invest       Date:  1963-11       Impact factor: 14.808

2.  [FAMILIAL MALFORMATION COMPLEX WITH UMBILICAL HERNIA AND MACROGLOSSIA--A "NEW SYNDROME"?].

Authors:  H R WIEDEMANN
Journal:  J Genet Hum       Date:  1964-09

Review 3.  The somatomedins. A new class of growth-regulating hormones?

Authors:  J J Van Wyk; L E Underwood; R C Lister; R N Marshall
Journal:  Am J Dis Child       Date:  1973-11

4.  Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses.

Authors:  Z Laron; A Pertzelan; M Karp; A Kowadlo-Silbergeld; W H Daughaday
Journal:  J Clin Endocrinol Metab       Date:  1971-08       Impact factor: 5.958

5.  Metabolic aspects of the Beckwith-Wiedemann syndrome.

Authors:  D Schiff; E Colle; D Wells; L Stern
Journal:  J Pediatr       Date:  1973-02       Impact factor: 4.406

6.  Plasma somatomedin activity in obese-hyperglycemic mice.

Authors:  G S Spencer; M B Enser
Journal:  Horm Metab Res       Date:  1979-10       Impact factor: 2.936

7.  New syndrome of neonatal hypoglycemia. Association with visceromegaly, macroglossia, microcephaly and abnormal umbilicus.

Authors:  J T Combs; J A Grunt; I K Brandt
Journal:  N Engl J Med       Date:  1966-08-04       Impact factor: 91.245

8.  A rapid simplified bioassay for somatomedin.

Authors:  G S Spencer; A M Taylor
Journal:  J Endocrinol       Date:  1978-07       Impact factor: 4.286
  8 in total
  8 in total

1.  Molecular analysis of patients with Wiedemann-Beckwith syndrome. II. Paternally derived disomies of chromosome 11.

Authors:  A Nyström; J E Cheetham; W Engström; P N Schofield
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

2.  Wiedemann-Beckwith syndrome: presentation of clinical and cytogenetic data on 22 new cases and review of the literature.

Authors:  M J Pettenati; J L Haines; R R Higgins; R S Wappner; C G Palmer; D D Weaver
Journal:  Hum Genet       Date:  1986-10       Impact factor: 4.132

3.  Somatomedin-c in the Beckwith-Wiedemann syndrome.

Authors:  M Robinow; A D Shafer
Journal:  Arch Dis Child       Date:  1981-01       Impact factor: 3.791

Review 4.  Beckwith-Wiedemann syndrome and the insulin-like growth factor-II gene. Does the genotype explain the phenotype?

Authors:  D P Witte; K E Bove
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

Review 5.  Wiedemann-Beckwith syndrome.

Authors:  W Engström; S Lindham; P Schofield
Journal:  Eur J Pediatr       Date:  1988-06       Impact factor: 3.183

6.  Analysis of gene dosage on chromosome 11 in children suffering from Beckwith-Wiedemann syndrome.

Authors:  P N Schofield; S Lindham; W Engström
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

7.  Cerebral gigantism (Sotos syndrome). Compiled data of 22 cases. Analysis of clinical features, growth and plasma somatomedin.

Authors:  J M Wit; F A Beemer; P G Barth; J W Oorthuys; P F Dijkstra; J L Van den Brande; N J Leschot
Journal:  Eur J Pediatr       Date:  1985-07       Impact factor: 3.183

8.  Epigenetic silencing of beta-spectrin, a TGF-beta signaling/scaffolding protein in a human cancer stem cell disorder: Beckwith-Wiedemann syndrome.

Authors:  Zhi-Xing Yao; Wilma Jogunoori; Sanaa Choufani; Asif Rashid; Tiffany Blake; Wenguo Yao; Peter Kreishman; Rupen Amin; Anton A Sidawy; Stephen R T Evans; Milton Finegold; E Premkumar Reddy; Bibhuti Mishra; Rosanna Weksberg; Rakesh Kumar; Lopa Mishra
Journal:  J Biol Chem       Date:  2010-08-25       Impact factor: 5.157
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.